Cinnamon and Ibrance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cinnamon (cassia cinnamon) and Ibrance (palbociclib). Common drug interactions include fatigue among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Cinnamon and Ibrance. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Cinnamon?

Cinnamon has active ingredients of cassia cinnamon. It is often used in diabetes. eHealthMe is studying from 4,110 Cinnamon users. Check the latest studies of Cinnamon.

What is Ibrance?

Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,434 Ibrance users. Check the latest studies of Ibrance.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

36 people who take Cinnamon and Ibrance together, and have interactions are studied.

What are the common drug interactions of Cinnamon and Ibrance, by gender? *:

female:

Fatigue (feeling of tiredness)
Diarrhoea
Nasopharyngitis (inflammation of the nasopharynx)
Alopecia (absence of hair from areas of the body)
Hot flush (sudden feelings of heat)
Rash pruritic (redness with itching)
Pyrexia (fever)
Anaemia (lack of blood)
Blood glucose decreased
Insomnia (sleeplessness)

male:

Death

What are the common drug interactions of Cinnamon and Ibrance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Pain in extremity
Dry eye (lack of adequate tears)
Furuncle (infection of the hair follicle)
Muscle atrophy (a decrease in the mass of the muscle)
Parosmia (distortion of the sense of smell, as in smelling odours that are not present)
Pyrexia (fever)
Respiratory disorder (respiratory disease)
Skin disorder (skin disease)

60+:

Fatigue (feeling of tiredness)
Platelet count decreased
Nasopharyngitis (inflammation of the nasopharynx)
Alopecia (absence of hair from areas of the body)
Hot flush (sudden feelings of heat)
Rash pruritic (redness with itching)
Anaemia (lack of blood)
Blood glucose decreased
Insomnia (sleeplessness)
Loss of consciousness

What are the existing conditions these people have? *

Breast Cancer Female: 21 people, 58.33%
Breast Cancer: 7 people, 19.44%
Breast Cancer Metastatic: 5 people, 13.89%
Neoplasm Malignant (cancer tumour): 2 people, 5.56%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 5.56%
High Blood Pressure: 2 people, 5.56%
Eye Disorder: 2 people, 5.56%
Cardiac Failure Congestive: 2 people, 5.56%
Bone Disorder: 2 people, 5.56%
Blood Pressure Abnormal: 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Cinnamon and Ibrance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously